IDEX Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 9.1% to $105.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.2%, from $108.90M to $105.40M. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.70M | $52.00M | $54.90M | $58.00M | $56.80M | $80.50M | $84.50M | $83.20M | $87.30M | $85.10M | $119.50M | $108.90M | $112.10M | $115.90M | $105.40M |
| QoQ Change | — | +0.6% | +5.6% | +5.6% | -2.1% | +41.7% | +5.0% | -1.5% | +4.9% | -2.5% | +40.4% | -8.9% | +2.9% | +3.4% | -9.1% |
| YoY Change | — | — | — | +12.2% | +9.2% | +46.6% | +45.7% | +46.5% | +8.4% | +0.7% | +43.6% | +24.7% | +31.7% | -3.0% | -3.2% |